Investors

Shareholder Information

Incanthera plc's shares are traded on the Access Segment of AQSE Exchange Growth Market.

Symbol: INC

ISIN GB00BGL7YW15
LEI code 2138002HEV4UFBOEXQ97

There are no restrictions on the transfer of AQSE Securities.

The main country of operation is United Kingdom. Incorporated and registered in England and Wales with registered number 11026926.

Incanthera plc is subject to the City Code on Takeovers and Mergers.

Shareholder Analysis

No. of shares in issue: 74,082,871
Warrants outstanding: 18,084,417
Options outstanding: 7,350,000
Fully diluted: 97,942,288
Percentage of Shares in public hands: 43.95%
Percentage of Shares not in public hands: 56.05%

Major Shareholdings

Shareholder Percentage of Enlarged Ordinary Share Capital (%)
North West Fund Biomedical: 21.82%
Immupharma PLC:  13.37%
University of Bradford: 10.11%
Tyndall Investment Management 6.85%
Tim McCarthy (Director) 5.31%
Other Directors 3.79%
PDMR's 1.40%

Contact:

Head of Communications & Company Secretary
Suzanne Brocks
Suzanne.brocks@incanthera.com